Carregant...
Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
Ulipristal acetate (UPA) was introduced as a novel progesterone receptor modulator as effective therapy for symptomatic fibroids. Randomised clinical trials established its effectiveness in the management of heavy menstrual bleeding due to uterine leiomyomas. The trials did not find any significant...
Guardat en:
| Publicat a: | Adv Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854411/ https://ncbi.nlm.nih.gov/pubmed/33201387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01555-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|